Dr Olga Ilyichova was a Research Fellow at the Monash Institute of Pharmaceutical Sciences (Parkville, Australia) and a Postdoctoral Scientist at the Australian Synchrotron, ANSTO (Clayton, Australia). Olga received her BSc (Hons) in Applied Physics and Mathematics at the Moscow Institute of Physics and Technology (Russia), followed by a PhD in Biochemistry and Structural Biology at Monash University (Clayton, Australia) under the supervision of Professor Ashley Buckle.

In 2012, Olga moved to the Monash Institute of Pharmaceutical Sciences (MIPS) to join Professor Martin Scanlon’s group, where she gained extensive experience in Fragment Screening by X-Ray crystallography.

In 2021, in collaboration with ANSTO, Olga was appointed to lead the development of a new crystallographic ligand screening pipeline at the Australian Synchrotron. Current responsibilities include setting up the infrastructure, development, integration, and implementation of various computational tools to support large-scale crystallography-based screening experiments.      

Olga’s main research interests are in fragment screening by X-Ray crystallography, automation and the development of novel methodologies for high-throughput protein crystallographic screening.